Investing.com - Boston Scientific (NYSE: BSX) reported first quarter EPS of $0.56, $0.05 better than the analyst estimate of $0.51. Revenue for the quarter came in at $3.86B versus the consensus estimate of $3.68B.
Guidance
Boston Scientific sees Q2 2024 EPS of $0.57-$0.59 versus the analyst consensus of $0.56.
Boston Scientific sees FY 2024 EPS of $2.29-$2.34 versus the analyst consensus of $2.25.
Boston Scientific's stock price closed at $68.99. It is up 12.86% in the last 3 months and up 34.98% in the last 12 months.
Boston Scientific saw 4 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See Boston Scientific's stock price’s past reactions to earnings here.
According to InvestingPro, Boston Scientific's Financial Health score is "great performance".
Check out Boston Scientific's recent earnings performance, and Boston Scientific's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Should you invest $2,000 in BSX right now?
Before you buy stock in BSX, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is BSX one of them?
Reveal Undervalued Stocks Now